PLEASE NOTE: Legislative Information cannot perform research, provide legal advice, or interpret Maine law. For legal assistance, please contact a qualified attorney.
An Act To Prohibit Consideration of Naloxone Purchases in Life Insurance Underwriting
Be it enacted by the People of the State of Maine as follows:
Sec. 1.  24-A MRSA §2159-E  is enacted to read:
§ 2159-E. Discrimination against naloxone purchases prohibited in life insurance
Notwithstanding any other provision of law, an insurer authorized to do business in this State may not:
 
1.  Limit coverage.     Limit coverage or refuse to issue or renew coverage of an individual under any life insurance policy due to the fact that the individual has been issued a prescription for naloxone or has purchased naloxone;
 
2.  Determine rate for coverage.     Consider the fact that an individual has been issued a prescription for naloxone or has purchased naloxone in determining the premium rate for coverage of that individual under a life insurance policy; or
 
3.  Otherwise discriminate.     Otherwise discriminate in the offering, issuance, cancellation, amount of coverage, price or any other condition of a life insurance policy based solely and without any additional actuarial justification upon the fact that an individual has been issued a prescription for naloxone or has purchased naloxone.
 
SUMMARY
This bill prohibits a denial or limitation of coverage or an increase in insurance premiums under a life insurance policy based on the fact that an individual has been issued a prescription for naloxone or has purchased naloxone.